Detalles de la búsqueda
1.
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(1): 126-135, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33039584
2.
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 18(13): 2952-2961.e8, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32062041
3.
Effects of Medical Cannabis on Use of Opioids and Hospital Visits by Patients With Painful Chronic Pancreatitis.
Clin Gastroenterol Hepatol
; 17(12): 2608-2609.e1, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30664949
4.
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 17(8): 1533-1540.e2, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30268561
5.
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 17(12): 2497-2505.e1, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30625408
6.
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
Gastroenterology
; 155(3): 687-695.e10, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29857091
7.
Patients' Perceive Biologics to Be Riskier and More Dreadful Than Other IBD Medications.
Inflamm Bowel Dis
; 26(1): 141-146, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31300811
8.
Systematic review: hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System.
Aliment Pharmacol Ther
; 51(5): 527-533, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31990422
9.
Prognosticating the Course of Inflammatory Bowel Disease.
Gastrointest Endosc Clin N Am
; 29(3): 395-404, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31078243
10.
Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes.
Inflamm Bowel Dis
; 25(11): 1854-1861, 2019 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31050734
11.
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 24(11): 2461-2467, 2018 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29788240
12.
Beyond disease activity to overall disease severity in inflammatory bowel disease.
Lancet Gastroenterol Hepatol
; 2(9): 624-626, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28786381
Resultados
1 -
12
de 12
1
Próxima >
>>